Zotizalkib ( TPX-0131 ),Zotizalkib ( TPX-0131 )

Zotizalkib ( TPX-0131 ) | CAS 2648641-36-3

價(jià)格	詢價(jià)
包裝	50mg	100mg	500mg

最小起訂量	50mg
發(fā)貨地	湖北
更新日期	2026-07-23

QQ交談微信洽談

產(chǎn)品詳情

中文名稱:Zotizalkib ( TPX-0131 )	英文名稱:Zotizalkib ( TPX-0131 )
CAS:2648641-36-3	純度規(guī)格: 98.0% HPLC
產(chǎn)品類別: APIS
Zotizalkib ( TPX-0131 ): Zotizalkib ( TPX-0131 ) \| ALK inhibitor

TPX-0131 is a next-generation ALK inhibitor drug candidate currently being evaluated in our Phase 1/2 FORGE-1 clinical trial of patients with ALK+ advanced non-small lung cancer (NSCLC). It has been designed with a novel compact macrocyclic structure and has shown preclinical potent inhibition of wildtype and numerous ALK mutations, including the clinically observed G1202R solvent-front mutation and the G1202R/L1196M compound mutation.

關(guān)鍵字： Zotizalkib;TPX-0131;2648641-36-3;

公司簡(jiǎn)介

Wuhan Sun-shine Bio-technology Corporation Limited (Shanghai Sun-shine Chemical Technology Corporation Limited) is a high-tech enterprise engaged inR&D and sales of related compounds of new drugs, specialty pharmaceutical API, advanced intermediates, organic synthetic masonry, and high-end reagents, etc. The special services we provide include: the technical development of chiral drugs, the development of an active molecular library.

成立日期	2012-07-20 （15年）	注冊(cè)資本	壹拾萬(wàn)元整
員工人數(shù)	10-50人	年?duì)I業(yè)額	￥ 500萬(wàn)-1000萬(wàn)
主營(yíng)行業(yè)	中間體,醫(yī)藥原料	經(jīng)營(yíng)模式	工廠,定制,服務(wù)

武漢永璨生物科技有限公司

VIP 16年

公司成立：15年
注冊(cè)資本：壹拾萬(wàn)元整
企業(yè)類型：有限責(zé)任公司
主營(yíng)產(chǎn)品：醫(yī)藥中間體
公司地址：湖北省武漢市江夏區(qū)鄭店街道黃金工業(yè)園路20號(hào)國(guó)藥光谷南大健康科技城研發(fā)生產(chǎn)中心

進(jìn)入店鋪

詢盤

店內(nèi)推薦

Ro 24-7429 | CAS 139339-45-0

詢價(jià)

Brepocitinib | PF-06700841

￥1200

Ervogastat ( PF-06865571) | CAS 2186700-33-2

詢價(jià)